These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Use of generics will mean cost savings. Nelson G Internist; 1979 May; 20(4):6-8. PubMed ID: 10242132 [No Abstract] [Full Text] [Related]
3. Implications of the Lannett and Pharmadyne decisions. Vetrano AJ Am J Hosp Pharm; 1980 Apr; 37(4):537-40. PubMed ID: 7377217 [TBL] [Abstract][Full Text] [Related]
4. Additional generics on the market. FDA Drug Bull; 1986 Nov; 16(2):14-5. PubMed ID: 3817341 [No Abstract] [Full Text] [Related]
5. FDA takes action against firms in scandal over generic products. Pollner F Med World News; 1989 Sep; 30(17):14-5. PubMed ID: 10294736 [No Abstract] [Full Text] [Related]
6. Knowledge is power: legislative control of drug industry trade secrets. O'Reilly JT Spec Law Dig Health Care (Mon); 1987 May; 8(15):7-31. PubMed ID: 10281981 [No Abstract] [Full Text] [Related]
7. Generic drug purchasing. Mehl B Hosp Pharm; 1988 Feb; 23(2):162-4 contd. PubMed ID: 10286432 [No Abstract] [Full Text] [Related]
9. New York's generic drug substitution law. Kamen A N Y State Dent J; 1980 Nov; 46(9):599-604. PubMed ID: 6935574 [No Abstract] [Full Text] [Related]
10. Generics still a favorite Rx for savings. Wagner M Mod Healthc; 1990 May; 20(21):26-8, 30, 32-3. PubMed ID: 10104890 [TBL] [Abstract][Full Text] [Related]
11. Generic vs. brand name drugs--quality, not cost, is key issue. Stetler CJ Internist; 1979 May; 20(4):9-10, 12. PubMed ID: 10242133 [No Abstract] [Full Text] [Related]
12. Current issues in the pioneer versus generic drug wars. Safir PO Food Drug Law J; 1995; 50(2):335-9. PubMed ID: 10343002 [No Abstract] [Full Text] [Related]
14. Keeping prescription drugs safe and effective. Bryan PA Am Fam Physician; 1974 Nov; 10(5):189-93. PubMed ID: 4421343 [No Abstract] [Full Text] [Related]
15. Doctors are pivotal to prescription struggle. Chapman S Leg Aspects Med Pract; 1979 Mar; 7(3):42-4. PubMed ID: 423688 [No Abstract] [Full Text] [Related]
16. In U.S., biosimilars still await FDA decision. Finkelstein JB J Natl Cancer Inst; 2006 Apr; 98(7):435. PubMed ID: 16595775 [No Abstract] [Full Text] [Related]
17. Prescriptions enter the political arena. Regier H J Leg Med (N Y); 1974; 2(2):24-30. PubMed ID: 4545342 [No Abstract] [Full Text] [Related]
18. FDA issues requirement for retaining drug samples. Oncology (Williston Park); 1991 May; 5(5):176. PubMed ID: 1832001 [No Abstract] [Full Text] [Related]
19. Therapeutic equivalency of drugs. Fact or fiction? Stetler CJ Med Ann Dist Columbia; 1969 Jun; 38(6):297-300. PubMed ID: 5257886 [No Abstract] [Full Text] [Related]
20. The "new drug" status of generic copies: a factor in drug product selection. Abood RR Pharm Manage Comb Am J Pharm; 1979; 151(4):160-3. PubMed ID: 493374 [No Abstract] [Full Text] [Related] [Next] [New Search]